Nearly 15,000 Covid Vaccine Deaths in USA - and Rising
Nearly 15,000 Covid Vaccine Deaths in USA - and Rising
Follow @KnightsTempOrg!5,000 deaths from Covid vaccines so far in the USA. This is the official death toll, as recorded by the Vaccine Adverse Event Reporting System (VAERS) and reported by the Centers for Disease Control and Prevention (CDC).
As a proportion of the 379 million jabs given, the figure is not high. But it is significant, particularly when the vaccines are now being pushed on young people who are at effectively zero risk from covid itself. And most significant at all is the way in which the mainstream media - so keen to report every 'covid death', have simply refused to tell the public about the very real dangers from the vaccine.
Data released Sept. 17 by the Centers for Disease Control and Prevention (CDC) showed that between Dec. 14, 2020 and Sept. 10, 2021, a total of 701,561 adverse events following COVID vaccines were reported to the Vaccine Adverse Event Reporting System (VAERS). The data included a total of 14,925 reports of deaths — an increase of 419 over the previous week.
There were 91,523 reports of serious injuries, including the reports of deaths, during the same time period — up 3,352 compared with the previous week.
Excluding “foreign reports” filed in VAERS, 559,462 adverse events, including 6,756 deaths and 43,073 serious injuries, were reported in the U.S. between Dec. 14, 2020 and Sept. 10, 2021.
Of the 6,756 U.S. deaths reported as of Sept. 10, 12% occurred within 24 hours of vaccination, 17% occurred within 48 hours of vaccination and 31% occurred in people who experienced an onset of symptoms within 48 hours of being vaccinated.
In the U.S., 378.2 million COVID vaccine doses had been administered as of Sept. 10. This includes: 216 million doses of Pfizer, 148 million doses of Moderna and 15 million doses of Johnson & Johnson (J&J).
This week’s U.S. data for 12- to 17-year-olds show:
- 19,827 total adverse events, including 1,169 rated as serious and 19 reported deaths. Two of the 19 deaths were suicides.
The most recent deaths involve one report of two patients [VAERS I.D. 1655100] who died after their second dose of Pfizer, including a 13-year-old female.
Other recent reported deaths include a 15-year-old boy (VAERS I.D. 1498080) who previously had COVID, was diagnosed with cardiomyopathy in May 2021 and died four days after receiving his second dose of Pfizer’s vaccine on June 18, when he collapsed on the soccer field and went into ventricular tachycardia; and a 13-year-old girl (VAERS I.D. 1505250) who died after suffering a heart condition after receiving her first dose of Pfizer.
-
2,972 reports of anaphylaxis among 12- to 17-year-olds with 99% of cases
attributed to Pfizer’s vaccine. - 488 reports of myocarditis and pericarditis (heart inflammation) with 481 cases attributed to Pfizer’s vaccine.
- 106 reports of blood clotting disorders, with all cases attributed to Pfizer.
This week’s U.S. VAERS data, from Dec. 14, 2020 to Sept. 10, 2021, for all age groups combined, show:
- 20% of deaths were related to cardiac disorders.
- 54% of those who died were male, 42% were female and the remaining death reports did not include gender of the deceased.
- The average age of death was 72.9.
- As of Sept. 10, 3,650 pregnant women reported adverse events related to COVID vaccines, including 1076 reports of miscarriage or premature birth.
- Of the 2,783 cases of Bell’s Palsy reported, 50% were attributed to Pfizer vaccinations, 42% to Moderna and 8% to J&J.
- 593 reports of Guillain-Barré syndrome, with 39% of cases attributed to Pfizer, 33% to Moderna and 27% to J&J.
- 149,681 reports of anaphylaxis with 42% of cases attributed to Pfizer’s vaccine, 51% to Moderna and 7% to J&J.
- 9,260 reports of blood clotting disorders. Of those, 3,968 reports were attributed to Pfizer, 3,376 reports to Moderna and 1,866 reports to J&J.
- 2,452 cases of myocarditis and pericarditis with 1,545 cases attributed to Pfizer, 806 cases to Moderna and 93 cases to J&J’s COVID vaccine.
FDA panel overwhelmingly rejects Pfizer boosters for healthy people 16 to 65 years old
On Sept. 17, a panel of scientific advisors to the U.S. Food and Drug Administration (FDA) voted 16 to 2 against recommending a third shot of Pfizer’s COVID vaccine for healthy people 16 and older, but voted unanimously in favor of recommending the booster shot for the immunocompromised and all people 65 or older.